SEPTEMBER 11-13, 2O2O

WelcomeDamien Kenny & Ziyad M. Hijazion behalf of the Course Directors & Co-Directors

Educational Objectives

Accreditation

PICS Foundation

LIVE Virtual Daily Program Overview

5

Table of Contents

PICS-AICS 2020 Preview IssueVol. 20 - Issue 8A August 2020

Welcome

LIVE CASE DEMONSTRATIONS | TAPED CASES | HOT DEBATES

ABSTRACT SESSIONS | BREAKOUT SESSIONS

MY NIGHTMARE CASE IN THE CATH LAB

W W W . P I C S Y M P O S I U M . C O M

SAVE THE DATESAN DIEGO

MARRIOTT MARQUIS – SAN DIEGO MARINA

SEPTEMBER 4–7, 2O19 Focusing on the latest interventional catheter strategies for congenital and structural heart disease in children and adults.

@PICS_AICS

Colleagues,

First, we hope this message finds you and your families well in these most troubling times. As you will have heard, PICS 2020 has transitioned to a live online meeting due to the SARS-Cov-2 pandemic. We have been working extremely hard to ensure the meeting is as stimulating and educational as ever. We have shortened the meeting to three days; however, we have live cases from six international sites, with taped cases from another six international sites, as well as live online lectures and debates, breakout sessions, abstract presentations and online exhibits. We plan to transmit the meeting live and have worked tirelessly to ensure the format and transmissions will be as good quality and as captivating as any live television event!

The meeting will start on Friday, September 11th with live cases from Dublin and New York. We will have taped cases from the Mayo Clinic and New Orleans followed by a session on Fetal Interventions with world renowned experts giving us their insights on appropriate approaches now and in the future. Afternoon sessions include “Dealing with Complications” with a presentation by Dr. Albert Wu from Johns Hopkins on managing our own trauma through catastrophic events in the Cath Lab, as well as “Complex Issues Surrounding Septal Defect Closure.” The final session of the afternoon is the Oral Abstract presentation session with over 20 oral presentations across two different viewing rooms.

Register Online for PICS-AICS 2020

https://register.rcsreg.com/r2/pics2020/ga/top.html

5

1

7

10

LIVELIVE ONLINE ONLINE S Y M P O S I U MS Y M P O S I U MSEPTEMBER 11-13, 2O2O

2O2O2O2O

http://www.congenitalcardiologytoday.com


http://www.picsymposium.com/

https://twitter.com/pics_aics?lang=en

Enterprise Pediatric Reporting & Imaging Solutions for

Cath, Echo and MR

http://www.digisonics.com/cardiovascular-solutions/cardiovascular-specialties/pediatric/

3www.CongenitalCardiologyToday.com

On Saturday, September 12th, we will have live cases from London and Columbus, Ohio. There will be taped cases from San Diego and CHOP, with a morning session on Evolving Interventional Technologies. Afternoon sessions will include “Advances in Imaging and CFD” as part of our collaboration with 3DI3, with a simultaneous session for early career interventionists through the PICES Breakout Session. In the later afternoon, there is a breakout session for Nursing and Associated Professionals with a thought-provoking session on Interventions on Low Birth Weight Infants finishing with a debate on how best to manage a 1.7kg infant with symptomatic Tetralogy of Fallot!

On Sunday, September 13th we will have live cases from Memphis and Doha with taped cases from Dallas and Boston. There will be a morning session on Interventional Cardiac MRI. In the afternoon we will have sessions focusing on Structural and Adult Congenital Interventions and Lymphatic Interventions, as well as breakouts on Approaches for Venous Stenoses and Occlusion and My Best and Worst Interventions.

Of course, there will be challenges this year. We will not be able to host the annual 5K run, but we encourage participants to post pictures on the meeting platform of their own efforts to exercise during the meeting. We will announce the PICS Young Leadership Award and the Charlie Kleinman Scientific Scholarship Award just before the meeting. Unfortunately, we can not facilitate the Terry King Traveling Fellowship Award this year. We will, however, have posters displayed online during the meeting on a special Poster Board link. We will also have some time for Industry Sponsored Symposia which will add meaningfully to the meeting content.

It is frustrating that we can not all meet to learn from each other in person this year, but we can still learn from each other to ensure our patients continue to receive the best care we have to give. We encourage you to engage fully with our Live Online Meeting and we will have platforms for ongoing discussion and debate amongst participants, with access to international experts for challenging case discussions.

We look forward to interacting with you in September and, of course, seeing you very soon!

Damien Kenny and Ziyad M. Hijazi on behalf of the Course Directors and Co-Directors











WE’LL GET THROUGH THIS,TOGETHERWorking to support you and the patients you serve.

UC202014484 EN

https://www.medtronic.com/us-en/healthcare-professionals/therapies-procedures/cardiovascular/transcatheter-pulmonary-valve-replacement/about-therapy.html?cmpid=mdtcom_melody_index_redirect_CVG_SH_Melody_TPV_FY20


WE’LL GET THROUGH THIS,TOGETHERWorking to support you and the patients you serve.

UC202014484 EN

Accreditation

Rush University Medical Center will provide CME/CEU/ASRT credits.

Educational Objectives

PICS-AICS 2020 will provide physicians, nurses & technologists the opportunity to learn about many aspects of pediatric and adult congenital and structural interventional cardiology.

Learning Objectives

Upon completion of your participation in this educational activity, you intend to incorporate the following into your practice of medicine:

• Utilize new interventional technologies and current strategies developed for the management of children and adults with congenital and structural heart disease.

• Incorporate into your practice the techniques for the proper placement of percutaneous valves, stents and devices for occlusion of septal defects.

• Initiate advances in diagnosis, evaluation and therapies for children and adults with congenital heart disease.

• Identify the important factors which affect the long-term outcomes and quality of life in children and adults with congenital heart disease.

• Incorporate alternative management strategies to transcatheter management for patients with congenital and structural heart defects.

• Utilize new clinical research advances in the care of children and adults with congenital heart disease.

• Incorporate demonstrated practical techniques related to interventional cardiac therapies in patients with structural and congenital heart disease.

• Access the results of new research, and assess their potential applications to clinical practice.

• Improve basic knowledge and skills relevant to clinical practice.

• Assess the potential of technological innovations and advances to enhance clinical practice and problem solving.

https://www.medtronic.com/us-en/healthcare-professionals/therapies-procedures/cardiovascular/transcatheter-pulmonary-valve-replacement/about-therapy.html?cmpid=mdtcom_melody_index_redirect_CVG_SH_Melody_TPV_FY20

https://www.rush.edu/?utm_source=listing&utm_medium=organic&utm_campaign=yext

*

›

›

MC-00003-01-AB

››

www.pfmmedicalusa.com

›

›

D

FO

* * *designs* *

*

*

***

*

*

*Quality *products through *

experienced **

engineering & innovative

Without you, there is no us. THANK YOU.

https://www.pfmmedical.com/


PICS Foundation

The PICS Foundation has been organized exclusively for charitable, educational and scientific purposes.

The focus of the Foundation is to educate physicians and healthcare professionals involved in the care of children and adults with congenital and structural heart disease in the latest advances in the field of interventional therapies for congenital and structural cardiac defects. The PICS Foundation will provide educational meetings and materials to pediatric and adult cardiologists from all over the world. The PICS Foundation will also sponsor research in the area of congenital and structural heart disease.

The PICS Foundation may receive funding via: individual contributions and grants from hospitals and other members of the medical community, registration fees from attendees of the annual symposium, exhibit fees from vendors attending the annual symposium and funds from individual contributors.

The primary activity of the PICS Foundation will be conducting an annual meeting for healthcare professionals. The Pediatric & Adult Interventional Cardiac Symposium is an annual meeting that is attended by approximately 1,000 healthcare professionals from all around the world. The symposium consists of four days of lectures and live case operations.

If you would like to support the PICS Foundation, please contact:

Board of Directors

The PICS Foundation is a 501(c)(3) organization10151 Avenue N

Chicago, IL 60617

Ziyad M. Hijazi, MD President, Director, Secretary

Carlos AC Pedra, MD Director

Kimberly Ray, RN Director

Michaeleen Wallig Treasurer

Damien Kenny, MD Director

Ziyad M. Hijazi, MD Foundation [email protected]

Kimberly Ray, RNFoundation Director

[email protected]










*

›

›

MC-00003-01-AB

››

www.pfmmedicalusa.com

›

›

D

FO

* * *designs* *

*

*

***

*

*

*Quality *products through *

experienced **

engineering & innovative

Without you, there is no us. THANK YOU.


https://www.pfmmedical.com/

NuDEL®

CP Stent® Delivery System

EmeryGlide™

MR Conditional Guidewire

Nit-Occlud® PDACoil System For PDA Closure

MAKING A DIFFERENCE

NuDEL™ Indications for Use:The NuDEL is indicated for use in the treatment of native and/or recurrent coarctation of the aorta involving the aortic isthmus or fi rst segment of the descending aorta where there is adequate size and patency of at least one femoral artery associated with one or more of the following: acute or chronic wall injury; nearly atretic descending aorta of 3 mm or less in diameter; a non-compliant stenotic aortic segment found on pre-stent balloon dilation; a genetic or congenital syndrome associated with aortic wall weakening or ascending aortic aneurysm.

The NuDEL is indicated for use in the treatment of right ventricle to pulmonary artery (right ventricular outfl ow tract) conduit disruptions that are identifi ed during conduit pre-dilatation procedures performed in preparation for transcatheter pulmonary valve replacement.

Caution: Federal (USA) Law restricts this device to sale by or on the order of a physician. Contraindications: Clinical or biological signs of infection. Active endocarditis. Pregnancy. Contraindications (CoA only): Patients too small to allow safe delivery of the stent without compromise to the systemic artery used for delivery. Unfavorable aortic anatomy that does not dilate with high pressure balloon angioplasty. Curved vasculature. Occlusion or obstruction of systemic artery precluding delivery or the stent. Known allergy to aspirin, other antiplatelet agents, or heparin. Contraindications (RVOT only): Patients too small to allow safe delivery of the stent without injury to a systemic vein or to the right side of the heart. Warnings / Precautions: Administer appropriate anticoagulation therapy to reduce potential thrombosis. If the patient is not appropriately anticoagulated, thrombus formation may occur. The sheath must be fl ushed with heparinized saline via the proximal side port prior to introducing the delivery system into the body. The infl ated diameter of the stent should at least equal the diameter of the intended implant site. Excessive handling and manipulation of the covering while crimping the stent may cause the covering to tear off of the stent. Retracting the covered stent back into the sheath may cause the covering to catch and tear off of the stent. Do not exceed the RBP. An infl ation device with pressure gauge is recommended to monitor pressure. Pressure in excess of the RBP can cause balloon rupture and potential inability to withdraw the catheter into the sheath. Confi rm that the distal end of the introducer sheath is at least 2.5cm back from the most proximal image band before infl ating the outer balloon. Failure to do so may stretch the outer tubing and severely hinder balloon defl ation. Exercise caution when handling the stent to prevent breakage. The NuDEL system, especially at the stent, is rigid and may make negotiation through vessels diffi cult. The infl ation diameter of the balloon used during stent delivery should approximate the diameter of the obstructive vessel and the intended implant site. If resistance is encountered upon removal, the whole system (balloon, guidewire and sheath) should be removed as a single unit, particularly if balloon rupture or leakage is known or suspected. Warnings / Precautions (CoA only): Coarctation of the aorta involving the aortic isthmus or fi rst segment of the descending aorta should be confi rmed by diagnostic imaging. The NuMED CP Stent has not been evaluated in patients weighing less than 20kg. The platinum/iridium stent may migrate from the site of the implant. As with any type of implant, infection secondary to contamination of the stent may lead to aortitis, or abscess. Over-stretching of the artery may result in rupture or aneurysm formation. Warnings / Precautions (RVOT only): During the Premarket Approval study the Medtronic Melody valve was used for valve restoration. The safety and effectiveness of the Covered CP Stent for pre-stenting of the right ventricular outfl ow tract (RVOT) landing zone (i.e. prophylaxis or prevention of either RVOT conduit rupture or TPVR fracture; use as a primary RVOT conduit) in preparation of a transcatheter pulmonary valve replacement (TPVR) has not been evaluated. As with any type of implant, infection secondary to contamination of the stent might lead to endocarditis, or abscess formation. The Covered Stent can migrate from the site of implant potentially causing obstruction to pulmonary artery fl ow. Over-stretching of the RVOT may result in rupture or aneurysm of the RV-PA conduit or the native pulmonary artery.

Nit-Occlud® Indications for Use: The Nit-Occlud® PDA coil is a permanently implanted prosthesis indicated for percutaneous, transcatheter closure of small to moderate size patent ductus arteriosus with a minimum angiographic diameter less than 4mm.

Nit-Occlud® Brief Statement:Do not implant the Nit-Occlud PDA into patients who have endocarditis, endarteritis, active infection, pulmonary hypertension (calculated PVR greater than 5 Wood Units), thrombus in a blood vessel through which access to the PDA must be obtained, thrombus in the vicinity of the implantation site at the time of the implantation or patients with a body weight < 11 lbs. (5kg). An angiogram must be performed prior to implantation for measuring length and diameter of the PDA. Only the pfm medical implantation delivery catheter should be used to implant the device. Administration of 50 units of heparin per kg bodyweight should be injected after femoral sheaths are placed. Antibiotics should be given before (1 dose) and after implantation (2 doses) to prevent infection during the implant procedure. Do not implant the Nit-Occlud PDA in an MR environment. Do not pull the Nit-Occlud coil through heart valves or ventricular chambers. Contrast media should not be injected through the implantation catheter. The catheter must not be connected to high pressure injectors. Patients may have an allergic response to this device due to small amounts of nickel that has been shown to be released from the device in very small amounts. If the patient experiences allergic symptoms, such as diffi culty in breathing or swelling of the face or throat, he/she should be instructed to seek medical assistance immediately. Antibiotic prophylaxis should be performed to prevent infective endocarditis during fi rst 6 months after coil implantation. Potential Adverse Events: Air embolism, Allergic reaction to drug/contrast, Apnea, Arrhythmia requiring medical treatment or pacing, Arteriovenous fi stula, Bacterial endocarditis, Blood loss requiring transfusion, Chest pain, Damage to the tricuspid or pulmonary valves, Death, Embolization of the occluder, requiring percutaneous or surgical intervention, Endarteritis, False aneurysm of the femoral artery, Fever, Headache/ Migraine, Heart failure, Hemolysis after implantation of the occluder, Hypertension, Hypotension or shock, Infection, Myocardial infarction, Occluder fracture or damage, Perforation of the heart or blood vessels, Stenosis of the left pulmonary artery or descending thoracic aorta, Stroke/TIA, Thromboembolism (cerebral or pulmonary), Valvular Regurgitation, Vessel damage at the site of groin puncture (loss of pulse, hematoma etc.)

Refer to the IFUs for a complete listing of indications, contraindications, warnings and precautions. www.bisusa.org NuDEL is a trademark of NuMED, Inc. Nit-Occlud is a registered trademark of pfm medical, inc.Rx only CV-9112 Rev. 8/19 ©2019 B. Braun Interventional Systems Inc.

Distributed by:B. Braun Interventional Systems Inc. | Part of the B. Braun Group of Companies824 Twelfth Avenue | Bethlehem, PA 18018 | USATel 877-836-2228 | Fax 610-849-1334 | www.bisusa.org

10 PICS-AICS 2020

Friday, September 11th *All times listed in CST

POSTER Abstracts will be displayed daily

Daily Moderators Ziyad M. Hijazi & John P. Cheatham

8:00-9:20am Live Case Session 1Panelists Raul Arrieta, Hesham Al-Saloos, Masood Sadiq, Carlos Zabal, Alejandro Peirone, Mark Galantowicz 8:00-8:40 Dublin, Ireland8:40-9:20 New York

9:30-10:00am Taped Cases Moderators Lee Benson & Dave Balzer9:30-9:45 New Orleans, LA – Kiran Mallula9:45-10:00 Mayo Clinic – Allison Cabalka

10:00-10:20am Break & Industry Opportunities

10:20-11:40am Fetal InterventionsModerators Alex Javois & Vivian Dimas10:20-10:32 What I’ve Learned from 20 Years of Fetal Cardiac Interventions Wayne Tworetzky 10:34-10:46 How Do We Finally Answer the Question: Does Fetal Balloon Aortic Valvuloplasty Improve Outcomes?

Gerald Tulzer 10:48-11:00 What Registry Data Tell Us About Ideal Center Volume

Simone Fontes-Pedra 11:02-11:14 Tips and Tricks for Treating Fetal Pulmonary Atresia

Carlos Pedra 11:16-11:28 Fetal Transcatheter Pulmonary Valve Replacement

Aimee Armstrong11:30-11:40 Discussion/Questions

11:40-1:00pm Live Case Session 2Moderators Evan Zahn & William Hellenbrand Panelists Daniel Aguirre, Martin Bocks, Lynn Peng, Howard Weber, Richard Ringel, Ram Emani 11:40-12:20 Dublin, Ireland12:20-1:00 New York

1:00-2:00pm Break & Industry Sponsored Sessions

2:00-3:30pm Dealing with Complications (Main Session)Moderators Ralf Holzer & David Nykanen 2:00-2:12 Complications in the Cath Lab:

The Scope of the Problem and Its Impact Lisa Bergersen

2:14-2:26 Workflow and Management Strategies to Prepare for and Mitigate the Impact of Adverse Events in the Cath Lab

Ralf Holzer 2:28-2:40 The Impact of Simulations and Its Potential Use in the Congenital Cath Lab Kevin Ching 2:42-2:54 COVID19 – Cath Lab Preparation and Response to an External “Complication” Shyam Sathanandam 2:56-3:08 Dealing with a Catastrophic Event: How to Manage Our Own Trauma Albert Wu3:10-3:22 The Care After the Care: How Do You Translate Lessons From Complications Into Practical Improvements John Moore 3:22-3:30 Questions/Discussion

2:00-3:30pm Complex Issues Surrounding Septal Defect Closure

Moderators Joshua Murphy & Dan Levi 2:00-2:12 Anatomical Features of Complex ASD’s - Wet Lab

Mark Reisman 2:14-2:26 ASD Closure Using TTE - Tips and Tricks Xiang Bin Pan 2:28-2:40 Managing ASD and Atrial Arrhythmia in the Adult - Proposed Algorithm Teiji Akagi 2:42-2:54 Complex Retrieval Techniques Following ASD Device Embolization Jae Young Choi 2:56-3:08 Transcatheter VSD Closure from the RV - Patient Selection and Technique K. Sivakumar3:10-3:22 Update on Transcatheter Closure of Membranous VSD’s - How Far Can We Push? Worakan Promphan 3:22-3:30 Questions/Discussion

LIVE Virtual Daily Program Overview


3:30-4:00pm Break & Industry Opportunities

4:00-6:00pm Oral Abstract PresentationsRoom 1 Moderators Larry Latson, JV DeGiovanni, Craig Fleishman Room 2 Moderators Robert Vincent, Tom Forbes, Terry King

Saturday, September 12th *All times listed in CST


Daily Moderators Damien Kenny & Carlos Pedra

8:00-9:20am Live Case Session 3 Panelists Bargrat Alekyan, Gianfranco Butera, Bharat Dalvi, Makram Ebeid, Raul Rossi, Michel Ilbawi 8:00-8:40 London, England8:40-9:20 Columbus, Ohio

9:30–10:00am Taped CasesModerators Jacqueline Kreutzer & Phil Moore 9:30-9:45 San Diego, CA – Kanishka Ratnayaka9:45-10:00 CHOP – Matt Gilespie


10:20-11:40am Newer Stuff Moderators Julie Vincent & Mark Osten 10:20-10:30 Transcatheter Glenn Howaida El-Said 10:32-10:42 Transcatheter Electrointervention Robert Lederman 10:44-10:54 Transcatheter PA Banding with MVP Dietmar Schranz 10:56-11:06 VSD Enlargement Henri Justino 11:08-11:18 3-D Printing Stents Triona Lally 11:20-11:30 Tissue Engineered Valves Massimo Caputo 11:30-11:40 Questions/Discussion

11:40-1:00pm Live Cases Session 4 Moderators Felix Berger & Allison Cabalka Panelists Francois Godart, Brent Gordon, Jafar Husain, Dan Gruenstein, Levent Saltik, Olivier Ghez11:40-12:20 London, England 12:20-1:00 Columbus, Ohio


2:00-3:30pm Interventions on Low Birth Weight Infants (Main Session)

Moderators Thomas Fagan & Bryan Goldstein 2:00-2:12 Outcomes on VLBW Infants with CHD Not As Bad As We Thought? Patrick McNamara2:14-2:26 What Can the Surgeons Offer? Mark Galantowicz 2:28-2:40 Ideal Timing for Intervention in a 1kg Infant with Severe PS

Jeff Zampi 2:42-2:54 Workflow for Percutaneous Carotid Approach Chris Petit 2:56-3:08 Hybrid Approaches for LBW Infants – Case-Based Presentations of Our Learning Curve Brent Gordon Debate 1.7 kg Symptomatic Infant with Tetralogy of Fallot 3:10-3:20 Percutaneous Approach is Best David Balzer 3:20-3:30 Surgical Approach is Best Pedro del Nido3:30-3:40 Discussion

2:00-3:30pm PICES Breakout Session (Breakout)Moderators Ryan Callahan, Gurumurthy Hiremath, Tacy Downing, Wendy Whiteside, Sebastian GorecznyTopic “For the First Time – How to Adopt a New Procedure in the Lab"Business Meeting - 10 minPICES Mentorship Award - 10 minCase Presenter 1 (PICES Member 1) - 15 minCase Presenter 2 (PICES Member 2) - 15 minCase Presenter 3 versus Invited Junior Interventionalist (PICES Member 3) - 15 minsInvited Senior Interventionalist - 20 mins

4:00–5:30pm Advances in Imaging and CFD - 3DI3 (Main Session)

Moderators Mario Carminati, Gregor Krings, Aimee Armstrong 4:00-4:12 Overview of Advanced Imaging to Guide Complex Interventions Aimee Armstrong 4:14-4:26 MR and CT: What Do We Need for Cath Overlay?

Sebastian Goreczny 4:28-4:40 CTA Fusion and 3DRA in Complex PPVI Tom Fagan

The All-In-One Stent System

1639

NuDELTriaxial BIB Catheter

with Sheath & CoveredCP Stent for Coarctation

of the Aorta & RVOT

™

The NuDEL™ Stent Delivery System is designed for the efficient and effective treatment of Coarctation of the Aorta and RVOT Conduit Disruption.

The NuDEL™ includes a triaxial balloon in balloon designed catheter with a pre-mounted Covered CP Stent™, which is then covered by a sheath as an all-in-one system. Combining the proven technologies of the NuMED BIB® balloon catheter and the Covered CP Stent™, the NuDEL™ System employs both a compact delivery method and the “zig” pattern stent design.

The NuDEL™ System is available worldwide. Contact us or your local distributor to place an order.

World Leader in Pediatric Cardiology

NuMED I 2880 Main Street I Hopkinton, NY 12965 USA Tel: 315.328.4491 I Fax: 315.328.4941 I www.numedforchildren.com

The Only Class III Stent Approved

for Coarctation of the Aorta & RVOT

This device is subject to individual country regulations regarding the importation and sale of this product.

http://www.numedforchildren.com/


4:42-4:54 3DRA in Single Ventricle: When is it Worth it? Darren Berman 4:56-5:08 Update on Holography and AR/VR Elchanan Bruckheimer 5:10-5:22 Expect the Unexpected: Detect and Prevent Coronary and Airway Compression After Complex Biventricular Repair Gregor Krings5:22-5:30 Questions/Discussion

4:00-5:30pm Nursing and Associated Professionals Breakout Session (Breakout)

Moderators Sharon Cheatham & Karen Iacono4:00-4:12 Do you Really Need a Biplane- Imaging Cath Lab for CHD with Today’s Technology? Darren Berman4:14-4:26 Extreme Premie PDA Device Closure: Considerations for Safety and Efficacy Emily Kish4:28-4:40 Cath Lab Staff: Working Effectively with Different Personalities Taylor Dempkin4:42-4:54 It’s a New World….The Sterile Cath Lab Environment is No Different Than the O.R. T. Curtis Alford 4:56-5:08 How Did COVID-19 Influence the Cath Lab? Matt Crystal 5:10-5:22 Are Real Time MRI-Guided Cath Labs Ready for Prime Time?

Ileen Cronin 5:22-5:30 Questions/Discussion

Sunday, September 13th *All times listed in CST


Daily Moderators Thomas Jones & Damien Kenny

8:00-9:20am Live Case Session 5Panelists Shabana Shahanavaz, Wail Alkashkari, Horacio Faella, Marco Papa, Massimo Caputo, Hideshi Tomita8:00-8:40 Memphis, TN8:40-9:20 Doha, Qatar

9:30-10:00am Taped CasesModerators Matt Gillespie & Felix Berger 9:30-9:45 Dallas, TX - Suren Reddy 9:45-10:00 Boston, MA - Diego Porras


10:10-11:40am Interventional Cardiac MRIModerators Chris Petit & Kanishka Ratnayaka 10:10-10:22 Radiation Exposure – Are Current Advances in Dose Reduction Enough for Ourselves and Our Patients? Jeremy Asnes10:24-10:36 ICMR – Establishing a Program – What Do I Need?

Aimee Armstrong 10:38-10:50 ICMR – Workflows in an Established Program Toby Rogers10:52-11:04 ICMR – Where Could We Be in 10 Years? Robert Lederman Debate ICMR Will Replace Standard Fluoroscopic Imaging in the Next 20 Years 11:06-11:18 Pro – Alan Nugent 11:20-11:32 Con – Zahid Amin 11:32-11:40 Questions/Discussion

11:45-1:00pm Live Case Session 6Moderators John Carroll & Dan Levi Panelists Reda Ibrahim, Shelby Kutty, Joaquim Miro, Brian Morray, Pedro del Nido, Oscar Mendiz11:45-12:20 Memphis, TN12:20-12:55 Doha, Qatar


2:00-3:30pm Structural Interventions and Adult CHD – Update (Main Session)

Moderators Cliff Kavinsky & Allison Cabalka2:00-2:12 Mitraclip: Novel Use in CHD Patients Scott Lim 2:14-2:26 "No Footprint" Techniques for PFO Closure Horst Sievert 2:28-2:40 Reverse POTTS Shunt for Pulmonary HTN Younes Boudjemline 2:42-2:54 Transcatheter Tricuspid Valve Repair in CHD - What’s Available with Compassionate Use and On the Horizon?

Eric Horlick

14 PICS-AICS 2020

Debate Transcatheter Sinus Venosus ASD Closure Should be Performed in all Anatomically Suitable Candidates 2:56-3:08 Pro – Shakeel Qureshi 3:10-3:22 Con – Olivier Ghez

2:00-3:30pm Novel Approaches for Venous Occlusion and Stenosis (Breakout)

Moderators Tom Forbes & Nathan Taggart 2:00-2:12 Vascular Mapping for Optimizing Chronic Central Access

Frank Ing 2:14-2:26 Options for Acute Thrombus Retrieval Bryan Goldstein 2:28-2:40 Baffle Stenosis Post Atrial Redirection Surgery – Who Should We Treat?

Jamil Aboulhosn 2:42-2:54 An Algorithm for Treating Pulmonary Vein Stenosis in Infants Diego Porras 2:56-3:08 Rotational Angiography and Advanced Imaging Techniques to Guide Treatment of Acquired Pulmonary Vein Stenosis in Adults

Lourdes Prieto 3:10-3:22 Impact of Conduit Stenting on Fontan Hemodynamics – When Does it Help? Doff McElhinney 3:22-3:30 Questions/Discussion

4:00-5:35pm Lymphatic Interventions (Main Session) Moderators Gareth Morgan & Jose Luis Zunzunegui 4:00-4:12 What Do I Need to Start a Program? Petru Liuba 4:14-4:26 MR Lymphangiography – Key Elements for Successful Imaging Anna Lillis4:28-4:40 Classification System for Lymphatic Disorders as a Guide for Effective Treatment Algorithms Yoav Dori 4:42-4:54 Extending Beyond Plastic Bronchitis and PLE Chris Smith4:56-5:08 The Case I Wish I Had Not Done – Do’s and Don'ts Through the Learning Curve Yoav Dori 5:10-5:25 Taped Case – Periportal Lymphatic Embolization Marc Gewillig 5:25-5:35 Questions/Discussion

4:00-5:30pm My Best and Worst Interventions (Breakout)Moderators Phil Roberts & Matt Gillespie 4:00-4:12 PDA Stenting – Athar Qureshi 4:14-4:26 tPVR – Ahmet Celebi 4:28-4:40 VSD Closure – Dr. Tin 4:42-4:54 RVOT Stent – Mansour AlJufan4:56-5:08 Premmie PDA Case – Alain Fraisse 5:10-5:22 Pulmonary Outflow Perforation Mazeni Alwi 5:24-5:36 Questions/Discussion

5:40pm Closing Remarks


FOUNDER & SENIOR EDITOR

Tony [email protected]

EDITOR-IN-CHIEFKate [email protected]

CO-FOUNDER & MEDICAL EDITOR

John W. Moore, MD, [email protected]

EDITOR-IN-CHIEF EMERITUS

Richard Koulbanis

STAFF EDITORLoraine Watts

STAFF EDITOR & WRITER

Virginia Dematatis

Felipe Heusser, MDZiyad M. Hijazi, MD, MPH

Ralf Holzer, MDMarshall Jacobs, MD

R. Krishna Kumar, MD, DM, MBBSJohn Lamberti, MD

Gerald Ross Marx, MDTarek S. Momenah, MBBS, DCH

Toshio Nakanishi, MD, PhDCarlos A. C. Pedra, MDDaniel Penny, MD, PhD

James C. Perry, MD

Teiji Akagi, MDZohair Al Halees, MD

Mazeni Alwi, MDFelix Berger, MD

Fadi Bitar, MDJacek Bialkowski, MDMario Carminati, MD

Anthony C. Chang, MD, MBAJohn P. Cheatham, MD

Bharat Dalvi, MD, MBBS, DMHoracio Faella, MDYun-Ching Fu, MD

© 2020 by Congenital Cardiology TodayISSN 1554-7787 print. ISSN 1554-0499 electronic.

Published monthly. All rights reserved.

Statements or opinions expressed in Congenital Cardiology Today reflect the views of the authors and sponsors and are not necessarily the views of

Congenital Cardiology Today.

OFFICIAL PUBLICATION OF THE CHiP NETWORK

EDITORIAL BOARD

11500 Elk Horn DriveClarksburg, MD 20871 USA

CORPORATE TEAM

CORPORATE OFFICE

Shakeel A. Qureshi, MDP. Syamasundar Rao, MDAndrew Redington, MDCarlos E. Ruiz, MD, PhD

Girish S. Shirali, MDHorst Sievert, MD

Hideshi Tomita, MDGil Wernovsky, MD

Zhuoming Xu, MD, PhDWilliam C. L. Yip, MD

Carlos Zabal, MD

http://www.congenitalcardiologytoday.com

mailto:Tony%40cct.bz?subject=Question

mailto:Dr.John%40cct.bz?subject=Question

mailto:Kate%40cct.bz?subject=Question

SEPTEMBER 11-13, 2O2O

Documents

Transcript of SEPTEMBER 11-13, 2O2O